Emerging treatments
Verapamil
May inhibit insulin secretion at high doses, but evidence to support use in hypoglycemia is limited.
Phenytoin
May inhibit insulin secretion at high doses, but evidence to support use in hypoglycemia is limited.
Corticosteroids
In nonoperable insulin-like growth factor-II-secreting tumors, there are case reports of successful control of hypoglycemic symptoms by using an oral glucocorticoid.[57]
Use of this content is subject to our disclaimer